JP2008513472A5 - - Google Patents

Download PDF

Info

Publication number
JP2008513472A5
JP2008513472A5 JP2007532479A JP2007532479A JP2008513472A5 JP 2008513472 A5 JP2008513472 A5 JP 2008513472A5 JP 2007532479 A JP2007532479 A JP 2007532479A JP 2007532479 A JP2007532479 A JP 2007532479A JP 2008513472 A5 JP2008513472 A5 JP 2008513472A5
Authority
JP
Japan
Prior art keywords
hydrogen
haloalkyl
alkyl
haloalkoxy
halo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007532479A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008513472A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/033051 external-priority patent/WO2006034004A2/en
Publication of JP2008513472A publication Critical patent/JP2008513472A/ja
Publication of JP2008513472A5 publication Critical patent/JP2008513472A5/ja
Pending legal-status Critical Current

Links

JP2007532479A 2004-09-17 2005-09-16 システインプロテアーゼインヒビターの調製のための方法及び中間体 Pending JP2008513472A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61080604P 2004-09-17 2004-09-17
PCT/US2005/033051 WO2006034004A2 (en) 2004-09-17 2005-09-16 Processes and intermediates for preparing cysteine protease inhibitors

Publications (2)

Publication Number Publication Date
JP2008513472A JP2008513472A (ja) 2008-05-01
JP2008513472A5 true JP2008513472A5 (enExample) 2008-07-03

Family

ID=35899659

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007532479A Pending JP2008513472A (ja) 2004-09-17 2005-09-16 システインプロテアーゼインヒビターの調製のための方法及び中間体

Country Status (15)

Country Link
US (1) US7737300B2 (enExample)
EP (1) EP1799645A2 (enExample)
JP (1) JP2008513472A (enExample)
KR (1) KR20070061877A (enExample)
CN (1) CN101068783A (enExample)
AU (1) AU2005287046A1 (enExample)
BR (1) BRPI0515470A (enExample)
CA (1) CA2580065A1 (enExample)
CR (1) CR8993A (enExample)
EC (1) ECSP077321A (enExample)
IL (1) IL181792A0 (enExample)
MX (1) MX2007003118A (enExample)
NO (1) NO20071937L (enExample)
WO (1) WO2006034004A2 (enExample)
ZA (1) ZA200703102B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2521811A1 (en) 2003-09-18 2005-03-31 Axys Pharmaceuticals, Inc. Haloalkyl containing compounds as cysteine protease inhibitors
WO2006060810A1 (en) 2004-12-02 2006-06-08 Schering Aktiengesellschaft Sulfonamide compounds as cysteine protease inhibitors
PL1865940T3 (pl) 2005-03-21 2013-06-28 Virobay Inc Alfa-ketoamidowe związki jako inhibitory proteaz cysteinowych
JP5215167B2 (ja) * 2005-03-22 2013-06-19 ビロベイ,インコーポレイティド システインプロテアーゼ阻害剤としてのスルホニル基含有化合物
US20090270511A1 (en) * 2006-09-08 2009-10-29 Merck Frosst Canada Ltd. Prodrugs of inhibitors of cathepsin s
WO2008037072A1 (en) 2006-09-25 2008-04-03 Merck Frosst Canada Ltd. Cathepsin b inhibitors
DK2079683T3 (en) 2006-10-04 2015-04-27 Virobay Inc Difluoro-containing compounds as cysteine protease inhibitors
US7893112B2 (en) 2006-10-04 2011-02-22 Virobay, Inc. Di-fluoro containing compounds as cysteine protease inhibitors
US8450336B2 (en) 2006-12-14 2013-05-28 Nps Pharmaceuticals, Inc Use of D-serine derivatives for the treatment of anxiety disorders
AU2008234380B2 (en) * 2007-04-02 2013-01-24 Merck Canada Inc. Amidation process for the preparation of cathepsin K inhibitors
HRP20150882T1 (hr) 2008-10-17 2015-09-25 Xenon Pharmaceuticals Inc. Spirooksindolski spojevi i njihova upotreba kao terapijska sredstva
US20120101053A1 (en) * 2009-06-22 2012-04-26 Cameron Black Cathepsin cysteine protease inhibitors for the treatment of various diseases
US8324417B2 (en) 2009-08-19 2012-12-04 Virobay, Inc. Process for the preparation of (S)-2-amino-5-cyclopropyl-4,4-difluoropentanoic acid and alkyl esters and acid salts thereof
WO2012119941A1 (en) 2011-03-04 2012-09-13 Prozymex A/S Peptidyl nitrilcompounds as peptidase inhibitors
JP2014518218A (ja) * 2011-06-17 2014-07-28 ビロベイ,インコーポレイティド 中枢神経系におけるミクログリア媒介ニューロン消失を処置するためのカテプシン阻害剤
CN106478564B (zh) * 2015-08-29 2021-11-12 广东东阳光药业有限公司 组织蛋白酶k抑制剂及其用途
CN107922315B (zh) * 2015-08-29 2021-03-26 广东东阳光药业有限公司 组织蛋白酶k抑制剂及其用途
AU2020250933A1 (en) 2019-04-05 2021-10-28 Centre Hospitalier Régional Et Universitaire De Brest Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxic poisoning

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723407D0 (en) * 1997-11-05 1998-01-07 Ciba Geigy Ag Organic compounds
HUP0004400A3 (en) * 1997-11-05 2002-10-28 Novartis Ag Dipeptide nitriles, process for their preparation, pharmaceutical compositions comprising thereof and their use
AU2560300A (en) * 1999-02-20 2000-09-04 Astrazeneca Ab Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsins
EP1434769A2 (en) * 2001-10-02 2004-07-07 Boehringer Ingelheim Pharmaceuticals Inc. Compounds useful as reversible inhibitors of cysteine proteases
RU2312861C2 (ru) * 2002-03-05 2007-12-20 Мерк Фросст Кэнада Лтд. Ингибиторы катепсин-цистеинпротеазы
DE60232547D1 (de) * 2002-03-11 2009-07-16 Kao Corp Kosmetika

Similar Documents

Publication Publication Date Title
CY2020012I1 (el) Προφαρμακα των ενωσεων 2,4-πυριμιδινδιαμινης και οι χρησεις αυτων
JP2008506632A5 (enExample)
ZA200804782B (en) Photochromic materials having electron-withdrawing substituents
BRPI0818958A2 (pt) "processos para a fabricação dos hidrofluoroalquenos, para a fabricação dos hidrofluoroalcanóis, para a fabricação dos hidrofluoroésteres e composto"
WO2007048064A3 (en) Amino-pyrimidines as casein kinase ii (ck2) modulators
WO2006058700A8 (en) Acetamide compounds as fungicides
EP1938155A4 (en) BUSINESS PROCESS EXECUTE ENGINE
IL192867A (en) Soft-gelatin capsule formulation
WO2009064374A3 (en) Oral formulations of bis(thiohydrazide amides)
ATE531717T1 (de) Neue kristalline form eines pyridazinoä4,5- büindolderivats
IT1366567B (it) Granulati espandibili a basemdi polimeri vinilaromatici dotati di migliorata espansibilita'e procedimento per la loro preparazione
DE602005000415D1 (de) Tintenstrahl-Aufzeichnungsblatt
ZA200707933B (en) Substituted aryl 1.4-pyrazine derivatives
BRPI0812460A2 (pt) " compostos orgânicos ".
JP2009215399A5 (enExample)
ATE533756T1 (de) N-formyl-hydroxylamin-verbindungen
BRPI0610156A2 (pt) forma micronizada de um composto, forma purificada i do composto, kit, padrão de referência, e, método de preparaçao de uma composição farmacêutica.
NO20050885D0 (no) Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
PL377747A1 (pl) Synteza amidu kwasu 3-(4-hydroksyfenylo) propanowego
JP2009507121A5 (enExample)
JP2005298393A5 (enExample)
JP2005298653A5 (enExample)
JP2008528720A5 (enExample)
JP2010504415A5 (enExample)
ZA200902732B (en) Method for the synthesis of n-[3-(2-methoxyphenyl)sulfanyl]-2-methoylpropyl]-3,4-dihydro-2h-1,5-benzoxathiepin-3-amine